U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Quality Management System – Lead - Qms

Regulatory & Quality (Life Sciences)Updated on Nov 14
Full-timeBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • A bachelor's or master's degree, or education in a relevant scientific discipline.
  • Fluent English communication, both oral and written; additional languages are a plus.
  • Deep, sustained, and current knowledge of Quality Systems in the regulated biopharmaceutical industry, particularly Quality Management Systems and related operations involving processes, systems, and personnel.
  • Comprehensive working knowledge of data integrity and risk management, including risk assessment and mitigation.
  • Thorough understanding of current regulatory requirements and expectations, including those in the United States, Europe, Japan, and China, and the ability to interpret regulations and requirements in product development and clinical-trial contexts.
  • Excellent presentation skills and the ability to present influentially and compellingly to senior management.
  • Ability to work independently with minimal supervision while contributing proactively as a team member.
  • Ability to present complex projects and issues to senior management clearly, succinctly, and coherently.
  • Negotiation skills and a proven ability to influence senior leaders and others in a global matrix organization.
  • Ability to adapt delivery of strategy, process, or training messages to different audiences in an engaging, collaborative, and influential manner.
  • Knowledge of risk analysis techniques, including Failure Mode and Effects Analysis; ability to identify and evaluate risks and propose mitigation plans in complex situations.
  • Proven analytical and investigation skills for understanding global, complex compliance and regulatory issues.
  • Excellent planning and organizational skills, including the ability to prioritize according to company priorities, compliance, and patient-safety risk.

Responsibilities

  • Develop and execute the Corporate Quality System strategy in alignment with UCB's Patient Value Strategy and objectives.
  • Develop, design, and ensure the QMS remains current with data integrity, data analytics, and risk management, including risk assessment and mitigation, while preserving process agility and flexibility.
  • Ensure QMS deployment, periodic senior-management review, and lifecycle management using the Regulatory Intelligence Network process and industry benchmarking.
  • Manage and develop the QMS lifecycle process as Quality QMS owner, considering the impact and involvement of people, processes, and systems.
  • Lead QMS governance in alignment with the enterprise QMS framework.
  • Develop and launch the QMS Maturity Program with senior management in Early Solutions, Development Solutions, and Supply & Technology Solutions, and maintain a QMS roadmap for the relevant GxP scope activities.
  • Design and build Corporate Process Owner governance within the overarching GxP CPO governance, and guide the QMS Process Owner community within Quality and relevant business organizations.
  • Serve as the point of contact for QMS questions and process-improvement initiatives or projects.
  • Assess the resources, systems, organizational effort, and impact of continuous-improvement requests or additions of new processes, and prioritize their execution.
  • Align QMS principles and ways of working across functional areas by engaging key stakeholders, functional teams, and Process Owners.
  • Define the training strategy for the relevant GxP-scope QMS and its deployment with the Head of DevSol Learning and business leaders.
  • Provide guidance on interpreting national and international regulations and guidelines relevant to the specific GxP scope.
  • As the QMS subject-matter expert for the relevant GxP scope, work with stakeholders to design, develop, and deliver QMS-related training and competency assessments as needed.
  • Define and implement process measurement metrics and maturity key performance indicators with Business QMS Leads to assess the maturity of the relevant GxP-scope QMS.
  • Lead senior-management-identified improvement initiatives to improve Quality Management processes, associated systems, stakeholder engagement, and effectiveness.
  • Foster a change-management culture that supports adoption and use of new ways of working.
  • Partner with functional units to identify and mitigate compliance risks, resolve potential regulatory observations, escalate critical compliance risks to senior management, and use internal resources and subject-matter experts to develop action plans and decisions.
  • Maintain strategic oversight of the relevant GxP-scope QMS end-to-end documentation architecture, linking processes and documents, and ensure enterprise standards are applied.
  • Coordinate and manage gap analysis for the relevant GxP-scope QMS with functional QMS Leads, assessing impact on functional or local documents, processes, systems, and people.
  • Support health-authority inspections and customer audits at UCB sites, and inspections of UCB Quality Management Systems as needed; serve as the point of contact for Process Owners.
  • Partner with operational QA teams to prepare sites for pre-approval and routine regulatory inspections.
  • Maintain oversight of corrective and preventive actions related to QMS processes arising from inspections and audits.

Desired Qualifications

  • Any additional language is a plus.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs